Procter & Gamble’s Vicks Contributes $1M Funding To Assist Front Line Health Workers of COVID-19

By John F. Heerdink, Jr.

The Procter & Gamble Company (PG)’s Vicks® family of cold and flu brands – NyQuil™, DayQuil™ and VapoRub™ are donating $1 million to Direct Relief, a humanitarian aid organization aiming to improve the health and lives of people affected by poverty or emergencies, including COVID-19.

The funds are meant to assist front line health workers, equipping them with protective gear and essential medical aid to health care organizations to meet the increasing number of COVID-19 patients in ICU.

“As a leader in consumer health for more than 125 years, Vicks has always focused on providing care and promoting relief in times of need. This time is no different – we must come together to help those most in need, which is why Vicks is helping to support health care workers on the front line,” stated Paul Gama, President-Elect, Global P&G Personal Health Care.  

To learn more about Procter & Gamble (PG) and to continue to track its progress please visit the Vista Partners Procter & Gamble Coverage Page

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives. 

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.


Post View Count : 537
(Read Original Story: Vicks® Donates $1 million for COVID-19 Health Care Relief in Business Wire)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us